rs2228373

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014000.3(VCL):​c.1506G>A​(p.Arg502Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0148 in 1,614,038 control chromosomes in the GnomAD database, including 1,801 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 933 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 868 hom. )

Consequence

VCL
NM_014000.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.575

Publications

3 publications found
Variant links:
Genes affected
VCL (HGNC:12665): (vinculin) Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
VCL Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1W
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy 15
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 10-74094424-G-A is Benign according to our data. Variant chr10-74094424-G-A is described in ClinVar as Benign. ClinVar VariationId is 45580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.575 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCLNM_014000.3 linkc.1506G>A p.Arg502Arg synonymous_variant Exon 11 of 22 ENST00000211998.10 NP_054706.1
VCLNM_003373.4 linkc.1506G>A p.Arg502Arg synonymous_variant Exon 11 of 21 NP_003364.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCLENST00000211998.10 linkc.1506G>A p.Arg502Arg synonymous_variant Exon 11 of 22 1 NM_014000.3 ENSP00000211998.5

Frequencies

GnomAD3 genomes
AF:
0.0621
AC:
9451
AN:
152114
Hom.:
933
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0242
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.00192
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00466
Gnomad OTH
AF:
0.0425
GnomAD2 exomes
AF:
0.0193
AC:
4848
AN:
251062
AF XY:
0.0154
show subpopulations
Gnomad AFR exome
AF:
0.214
Gnomad AMR exome
AF:
0.0117
Gnomad ASJ exome
AF:
0.0203
Gnomad EAS exome
AF:
0.00180
Gnomad FIN exome
AF:
0.000462
Gnomad NFE exome
AF:
0.00514
Gnomad OTH exome
AF:
0.0121
GnomAD4 exome
AF:
0.00989
AC:
14452
AN:
1461806
Hom.:
868
Cov.:
31
AF XY:
0.00904
AC XY:
6572
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.217
AC:
7270
AN:
33476
American (AMR)
AF:
0.0131
AC:
587
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
520
AN:
26132
East Asian (EAS)
AF:
0.000957
AC:
38
AN:
39700
South Asian (SAS)
AF:
0.00317
AC:
273
AN:
86250
European-Finnish (FIN)
AF:
0.000524
AC:
28
AN:
53416
Middle Eastern (MID)
AF:
0.0212
AC:
122
AN:
5768
European-Non Finnish (NFE)
AF:
0.00405
AC:
4503
AN:
1111964
Other (OTH)
AF:
0.0184
AC:
1111
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
883
1766
2649
3532
4415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0622
AC:
9470
AN:
152232
Hom.:
933
Cov.:
32
AF XY:
0.0600
AC XY:
4462
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.207
AC:
8589
AN:
41484
American (AMR)
AF:
0.0241
AC:
369
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3472
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5186
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00466
AC:
317
AN:
68032
Other (OTH)
AF:
0.0421
AC:
89
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
389
777
1166
1554
1943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0314
Hom.:
218
Bravo
AF:
0.0713
Asia WGS
AF:
0.0150
AC:
53
AN:
3478
EpiCase
AF:
0.00627
EpiControl
AF:
0.00528

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 26, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 04, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1W Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 21, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
7.7
DANN
Benign
0.85
PhyloP100
0.57
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228373; hg19: chr10-75854182; COSMIC: COSV53016225; API